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Introduction: Contrary to early beliefs, celiac disease (CD) is
relatively common; however, it still remains underdiagnosed
since most cases are atypical, with few or no gastrointestinal
symptoms and predominance of extraintestinal manifestations.
As a consequence, the diagnosis of the disorder often requires a
multidisciplinary approach. Also some oral ailments have been
described in celiac patients. In this study, we review the papers
that have reported oral manifestations in subjects with CD.
Methods: A comprehensive literature search was conducted in
Medline and Embase databases using appropriate key words.
Additional papers were selected by cross-referencing from the
retrieved articles.
Results: Dental enamel defects are the oral lesions most closely
related to CD. There are conﬂicting data on the association
between CD and recurrent aphthous stomatitis. A correlation of
CD with atrophic glossitis has been reported, although robust
evidence in support of it is lacking. Patients with CD have caries
indexes seemingly lower than healthy individuals, but they may
experience delay in tooth eruption. Occurrence of other oral
mucosal lesions in CD subjects is likely occasional.
Conclusions: Patients with systematic dental enamel defects
should be screened for CD even in the absence of gastro-
intestinal symptoms. CD screening tests for patients with oral
aphthae or idiopathic atrophic glossitis should be selectively
considered during a medical evaluation that focuses on all
aspects of the patient’s status.
Key Words: atrophic glossitis, case-ﬁnding, celiac disease, dental
enamel defects, recurrent aphthous stomatitis
(J Clin Gastroenterol 2008;42:224–232)
Celiac disease (CD) is a lifelong immune-mediateddisorder triggered by the ingestion of wheat gluten
and related proteins of rye and barley in genetically
susceptible subjects, which results in small intestinal
mucosal injury and nutrient malabsorption.
Until recently considered a rare condition, CD is
now well-known to be relatively common; its estimated
prevalence in the general population of North America
and Western Europe appears to be close to 1%, with a
reasonable range of 0.71% to 1.25%.1 The dramatic
advances made during the last decade in the under-
standing of CD have revealed the disease to have a
heterogeneous, wide, and often unsuspected range of
clinical presentations. In fact, today it is apparent that the
‘‘classic’’ clinical form (characterized by a malabsorption
syndrome, ie, chronic diarrhea, abdominal pain and
distention, weight loss) is less common, and most patients
have atypical CD, with few or no gastrointestinal
symptoms and predominance of extraintestinal manifes-
tations, such as short stature, iron-deﬁcient anemia,
abnormalities in liver function test.2 CD patients are
prone to develop long-term complications (eg, osteoporo-
sis, infertility, autoimmune diseases, malignancies),3 and
some studies report an increased all-cause mortality
compared with the general population.4,5 Strict and
lifelong adherence to a gluten-free diet (GFD) is the only
treatment currently available, and usually results in
remission. Compelling evidence suggests that GFD may
prevent or reduce the risk of long-term complications.3
The wide range of the CD clinical manifestations
should induce many diﬀerent specialists to consider this
disorder when a patient presents with those extraintest-
inal signs and symptoms that might be related to CD.6 In
this regard, also some oral ailments have been reported as
possible atypical aspects of CD, mainly dental enamel
defects (DEDs) and recurrent aphthous stomatitis (RAS).
The aim of our study was to review the papers that have
described oral manifestations in subjects with CD.
METHODS
A comprehensive literature search was conducted in
Medline and Embase databases using the key words
‘‘celiac disease,’’ ‘‘coeliac disease,’’ and ‘‘dermatitis
herpetiformis’’ combined separately with the terms ‘‘oral
cavity,’’ ‘‘oral lesions,’’ ‘‘dental enamel defects,’’ ‘‘recur-
rent aphthous stomatitis,’’ ‘‘oral ulcers,’’ ‘‘glossitis,’’
‘‘Plummer-Vinson syndrome,’’ ‘‘oral lichen planus,’’
‘‘dental caries,’’ ‘‘dental decay,’’ and ‘‘dental age.’’
Potentially relevant papers were selected on the basis of
title and abstract, and the full manuscripts were retrieved
and reviewed. For papers that were neither in English norCopyright r 2008 by Lippincott Williams & Wilkins
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Italian, only the abstract was reviewed; if no abstract was
available, the article was discarded. Additional papers
were selected by a manual search of the reference lists of
the retrieved articles.
CD AND ORAL HARD TISSUE LESIONS
DEDs
During enamel matrix deposition and calciﬁcation,
genetic and/or environmental factors can cause DEDs,
which may be quantitative or qualitative. Disturbances in
matrix secretion can cause enamel hypoplasia, which
presents as deﬁciency of enamel quantity, whereas
qualitative defects present as enamel opacity and are
due to disruptions occurring during the calciﬁcation
phase of enamel formation.7
An association between gastrointestinal diseases
and developmental defects of dental enamel was described
since early 1900s, when the term ‘‘dental atrophy’’ was
used for dental malformations owing to disorders
interfering with a normal nutrition.8 In 1955, pronounced
DEDs were described in a 7-year-old girl with clinical
features of CD,9 and in 1956, 7 patients with CD were
examined, 3 of whom exhibited DEDs of the permanent
dentition.10 Thereafter, other cases of DEDs in subjects
with CD were reported,10,11 and 8 out of 18 celiac
children had DEDs of permanent teeth in a series
reviewed in 1973.12
To the contrary, only 9 out of 252 patients with CD
were described as having mild to severe enamel hypoplasia
in a study realized in 1980.13 Besides, the ﬁrst controlled
study available in English literature which investigated the
presence of DEDs in CD patients reported no signiﬁcant
diﬀerence between celiac subjects and healthy controls.14
However, in 1986 Aine15 provided the strongest evidence
that DEDs may be an extraintestinal manifestation of CD,
reporting a 95.94% prevalence of DEDs of permanent
teeth in 74 children with CD. In this study, the celiac-type
DEDs were deﬁned as ‘‘systematic,’’ as they were
symmetrically and chronologically distributed in all 4
sections, reﬂecting the period in which disruptions inter-
fered with amelogenesis. The author proposed a grading
system (from grade I to IV) to classify the severity of the
CD-related enamel lesions, from simple opacities to severe
structural defects (Table 1).
Almost all the subsequent controlled studies re-
ported prevalence values of DEDs signiﬁcantly higher in
CD patients than in nonceliac individuals, and conﬁrmed
that the celiac-type enamel defects are systematic, as
diﬀerences for unspeciﬁc and unsystematic defects were
not signiﬁcant (Table 2).
The reason for the presence of DEDs in celiac
patients still remains not clear. Hypocalcemia due to
malabsorption could be a possible cause, in agreement
with the unifying hypothesis on mechanism of enamel
hypoplasia development.37 However, no diﬀerences in
mean serum calcium concentration were found between
celiac children with and without dental lesions,27 and
celiac-type DEDs were also detected in healthy ﬁrst-
degree relatives of celiac patients having normal small-
bowel mucosal architecture.38 So, a gluten-induced,
immune-mediated enamel damage should seem a more
likely cause of DEDs in celiac patients. Consistently with
this hypothesis, CD-associated dental changes were found
signiﬁcantly related to HLA antigen DR3.22,27 Further-
more, a strong association between the same HLA allele
and celiac-type DEDs were also demonstrated in healthy
ﬁrst-degree relatives of celiac patients.38 Hypocalcemia
resulting from malabsorption could be nevertheless a
contributing factor in inducing defective enamel forma-
tion.39
A few studies compared the prevalence of celiac-
type DEDs in deciduous and mixed/permanent dentition,
and all of these reported that they are more prevalent in
the mixed/permanent dentition.16,23,27 The overall pre-
valence of systematic CD-related DEDs in patients with
mixed/permanent dentition ranges from 9.52% to 95.94%
(with a mean value of 51.12%), whereas that for CD
patients with deciduous teeth is 5.88% to 13.33% (mean:
9.60%). The higher prevalence for the permanent denti-
tion could be explained by the fact that the development
of crowns of permanent teeth occurs between the early
months of life and the seventh year (ie, after the
introduction of gluten), whereas the formation of
deciduous teeth mainly occurs in utero. But the presence
of DEDs also in deciduous teeth supports the hypothesis
that immuno-genetical factors are more likely involved in
development of CD-related dental defects rather than
nutritional deﬁciencies, or at least these represent the
main cause.
The distribution of diﬀerent grades of DEDs
(according to the classiﬁcation of Aine) shows that grade
I and II defects are on the whole most common (Table 3).
It is unclear which factors aﬀect the severity of enamel
defects in CD patients. It was reported that the celiac-type
TABLE 1. Grading of the CD-related DEDs According
to Aine15
Grade DED
Grade I Defect in color of enamel
Single or multiple creams, yellow or brown opacities with
clearly deﬁned or diﬀuse margins; a part or the entire
surface of enamel is without glaze
Grade II Slight structural defects
Enamel surface rough, ﬁlled with horizontal grooves or
shallow pits; light opacities and discoloration may be
found; a part or the entire surface of enamel is without
glaze
Grade III Evident structural defects
A part or the entire surface of enamel rough and ﬁlled
with deep horizontal grooves which vary in width or
have large vertical pits; large opacities of diﬀerent
colors or strong discolouration may be in combination
Grade IV Severe structural defects
The shape of the tooth changed: the tips of cusps are
sharp-pointed and/or the incisal edges are unevenly
thinned and rough; the thinning of the enamel material
is easily detectable and the margins of the lesions are
well deﬁned; the lesion may be strongly discolored
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DEDs in adults are much less severe than in children,
despite a similar prevalence.31 In fact, no grade IV and
only 1 case of grade III defects were found out of 40 adult
celiac subjects (with a mean age at diagnosis of 34 y),
whereas nearly 30% of children with CD had grade III or
IV DEDs. This considerable diﬀerence could indicate that
the adult patients had had a clinically mild or atypical
disease at childhood, which had led to a late diagnosis
TABLE 2. Prevalence of DEDs in Patients With CD
Study Group
(Patients With CD)
Control Group
(Subjects Without CD)
Author, Year Dentition
Type of
DED
No.
Patients
Prevalence of
DED (%) No. Subjects
Prevalence of
DED (%)
CD Diagnostic
Criteria P
Bucci et al,16 2006 D, M, P Systematic 70 20 159 5.66 Biopsy <0.001
D Systematic 17 5.88 14 0 Biopsy NRb
M, P Systematic 53 24.53 145 6.20 Biopsy NR
Farmakis et al,17 2005 D Opac.,
hypopl.
13 92.30 13 46.15 NR <0.006
P Opac.,
hypopl.
15 60 15 20 NR <0.001
Ciacci et al,18 2005 P NR 360 16.11 — — Biopsy —
Priovolou et al,19 2004 M, P Any 18 83.33 18 50 ESPGAN,
1970
<0.03
M, P Systematic 18 44.44 18 11.11 ESPGAN,
1970
<0.02
Rasmusson et al,20 2001 M, P Opac.,
hypopl.
40 50 40 38 ESPGAN,
1970
0.26
La¨hteenoja et al,21 1998 D, M, P Systematic 128 10.16 — — Biopsy —
Aguirre et al,22 1997 M, P Any 137 52.55 52 42.30 Biopsy 0.2
M, P Unspeciﬁc 137 14.59 52 25 Biopsy 0.09
M, P Systematic 137 37.95 52 17.30 Biopsy 0.006
Rea et al,23 1997 D, M, P Systematic 45 24.44 105 4.76 ESPGAN,
1990
0.002
D Systematic 15 13.33 NR NR ESPGAN,
1990
—
M, P Systematic 30 30 NR NR ESPGAN,
1990
—
Ventura et al,24 1997 M, P Systematic 603 32.33 6949 0.74 ESPGAN,
1990
<0.00001
Martelossi et al,25 1996 M, P Systematic 90 53.33 6949 0.74 ESPGAN,
1990
NR
Bertoldi et al,26 1995 D, M, P Systematic 32 37.50 — — ESPGAN,
1990
—
Mariani et al,27 1994 D, M, P Systematic 82 28.04 189 14.81 ESPGAN,
1990
<0.005
Ballinger et al,28 1994 P Systematic 42 9.52 18 11.11 NR >0.05
Petrecca et al,29 1994 M, P Systematic 29 75.86 29 0 Biopsy NR
Aine et al,30 1992* P Any 30 100 66 92.42 — NR
P Unspeciﬁc 30 46.66 66 90.90 — NR
P Systematic 30 53.33 66 1.51 — <0.001
Aine et al,31 1990 P Any 40 100 112 93.75 Biopsy NR
P Unspeciﬁc 40 17.50 112 89.28 Biopsy NR
P Systematic 40 82.50 112 3.75 Biopsy <0.001
Balli et al,32 1988 D, M NR 49 34.69 — — SIP —
Prati et al,33 1987 D, M NR 10 33.33 15 0 Biopsy NR
Aine,15 1986 P Systematic 74 95.94 — — Biopsy —
Andersson-Wenckert
et al,14 1984
M, P Any 19 68.42 19 63.16 Biopsy NR
M, P Unspeciﬁc 19 15.78 19 15.78 Biopsy NR
M, P Systematic 19 52.63 19 47.36 Biopsy NR
Shmerling et al,13 1980 NR NR 252 3.57 — — NR —
Romankiewicz-Wozniczko
et al,12 1973
M, P NR 18 44.44 — — NR —
Miller, 1956w P NR 7 42.85 — — NR —
Hertz,9 1955 D, M NR 27 3.70 — — NR —
*This study was performed on patients with DH.
wData reported in Smith et al,10 1979.
D indicates deciduous; ESPGAN, European Society of Paediatric Gastroenterology and Nutrition (references of the diagnostic criteria: Meeuwisse,34 1970; Walker-
Smith et al,35 1990); hypopl, hypoplasias; M, mixed; NR, not reported, Opac, opacities; P, permanent; SIP, Societa` Italiana di Pediatria (Italian Society of Pediatrics;
reference of the diagnostic criteria: Italian Society of Pediatrics,36 1978).
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and slight dental lesions.31 In support of this hypothesis, a
correlation between the severity of CD clinical presenta-
tion and the grade of DEDs was also demonstrated.15
However, a higher prevalence of enamel lesions in
patients with atypical or asymptomatic CD was found,16
and a study on patients aﬀected by the CD-related
dermatitis herpetiformis (DH) demonstrated no correla-
tion between the degree of mucosal damage and the
presence of DEDs.30
The hypothesis that late diagnosis and prolonged
gluten exposure relate to the likelihood of DEDs was
supported by a few studies, which demonstrated that
mean age at diagnosis of CD is signiﬁcantly higher in
patients with dental defects,24,28 although others failed to
do so.16,27 Furthermore, in a series of 360 adults with CD,
no case of DEDs was described among patients with
proved CD diagnosis in childhood and on a strict
GFD since diagnosis, whereas DEDs were found in
18% of patients with early diagnosis but who were
reexposed to gluten, and in 26% of adults with newly
diagnosed CD.18
Concerning the location of the CD-related DEDs,
incisors are the teeth most frequently aﬀected, followed
by molars, canines, and premolars.16,22 This distribution
should seem related to the chronology of development of
the permanent dentition, as incisors and ﬁrst molars are
the ﬁrst teeth that undergo calciﬁcation; the lesser
involvement of teeth that calcify at a later stage could
be explained considering that their calciﬁcation starts
when CD has been possibly already diagnosed, and gluten
removed from diet.22 Instead, in nonceliac subjects dental
defects seem to be equally distributed for all the teeth,16,22
with signiﬁcant diﬀerence with respect to the involvement
of incisors as compared with CD patients.22 In regard to
the distribution of DEDs on the coronal surface, the
incisal third resulted the most aﬀected surface both in CD
and control groups; however, involvement of the incisal
two thirds or of the complete crown were also observed in
celiac patients, whereas none of the control group showed
this coronal involvement, and the diﬀerence resulted
statistically signiﬁcant.22
Dental Caries
Several studies investigated the prevalence of dental
caries in celiac patients. Some of these reported no
diﬀerence in caries prevalence between celiac individuals
and control healthy subjects.26,29,33,40 Rather surprisingly,
others found caries indexes signiﬁcantly lower in CD
subjects than controls.14,17,19,22 No study reported higher
dental caries prevalence among celiac patients. A possible
explanation for these ﬁndings is that the need for a
carefully controlled diet should make CD patients more
diet-conscious, so that they maybe have a low cariogenic
diet.14,17,22
Dental Age
Dental age was studied in 49 children with CD32:
delay in tooth eruption, estimated according to the dental
standard of Schour and Massler,41 was noticed in 28.57%
of patients. Similarly, the dental age was delayed in
relation to calendar age in one third of 38 children with
CD examined in a Polish study.42 Furthermore, we have
recently observed delayed eruption in 26% of pediatric CD
patients, as opposed to 7% of the controls (unpublished
observations). These ﬁndings are likely related to the
growth retardation, that is a typical sign of CD.
CD AND ORAL SOFT TISSUE LESIONS
RAS
RAS is characterized by painful, recurrent, single or
multiple ulcers of the oral mucosa, which are round
or ovoid and have an erythematous halos and a yellow or
gray ﬂoor. It is one of the most common mouth diseases,
aﬀecting 5% to 60% of the population depending on the
group studied43; it has been estimated that 20% of the
general population will suﬀer from RAS at some time in
their lives.44 Approximately 80% of patients with RAS
have minor aphthae, that are 2 to 8mm in diameter and
usually resolve spontaneously within 2 weeks. Major RAS
is much less common, with ulcers that may exceed 1 cm in
diameter and persist for several weeks. The least common
type of RAS is termed ‘‘herpetiform’’ and is characterized
TABLE 3. Distribution of Grades of CD-related DEDs
Author, Year Dentition
No. CD
Patients With
DEDs
No. CD Patients
With Grade I
DEDs (%)
No. CD Patients
With Grade II
DEDs (%)
No. CD Patients
With Grade III
DEDs (%)
No. CD Patients
With Grade IV
DEDs (%)
Bucci et al,16 2006 D, M, P 14 7 (50%) 4 (28.57%) 2 (14.28%) 1 (7.14%)
Priovolou et al,19 2004 M, P 15 12 (80%) 1 (6.66%) 0 (0%) 2 (13.33%)
Aguirre et al,22 1997 M, P 52 32 (61.54%) 16 (30.77%) 3 (5.77%) 1 (1.92%)
Rea et al,23 1997 D, M, P 11 5 (45.45%) 4 (36.36%) 2 (18.18%) 0 (0%)
Martelossi et al,251996 M, P 48 8 (16.66%) 22 (45.83%) 14 (29.17%) 4 (8.33%)
Petrecca et al,29 1994 M, P 22 10 (45.45%) 9 (40.90%) 2 (9.09%) 1 (4.54%)
Aine et al,30 1992* P 16 6 (37.50%) 10 (62.50%) 0 (0%) 0 (0%)
Aine et al,31 1990 P 33 15 (45.45%) 17 (51.51%) 1 (3.03%) 0 (0%)
Aine,15 1986 P 71 10 (14.08%) 39 (54.93%) 14 (19.72%) 8 (11.27%)
*This study was performed on patients with DH.
D indicates deciduous; M, mixed; P, permanent.
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by clusters of small ulcers (as many as 100 or more, 1 to
3mm in diameter) that tend to coalesce producing large
irregular ulcerations.
The term ‘‘recurrent aphthous stomatitis’’ should be
reserved for recurrent ulcers occurring in subjects without
systemic diseases, whereas ulcers that resemble RAS but
found in systemic disorders should be termed ‘‘aphthous-
like ulcers.’’45 However, these 2 expressions are often used
indistinctly, and all the papers we reviewed discussed
RAS as a possible CD-associated oral disease. So, herein
we use the term RAS as well, even though aphthouslike
ulcersshould be a more appropriate expression to describe
recurrent oral ulcerations in celiac patients.
An association between oral ulcers, diarrhea, and
weight loss has been described for more than 3
centuries,46 and the early studies that investigated the
prevalence of CD in patients aﬀected by RAS reported
very high values (Table 4). Notably, Ferguson et al46
quoted a 24.24% prevalence of CD in 33 patients with
RAS, and asserted the importance of performing jejunal
biopsy in subjects with recurrent aphthae. Subsequent
studies54–56 lessened this matter, albeit they reported CD
prevalence values higher than those expected for the
normal population, and thus supported the hypothesis of
a correlation between CD and RAS. On the contrary, in
1986 only 1 of 100 patients with RAS had histologic
evidence of CD,53 and no CD-aﬀected patient has been
recently described among 87 subjects with RAS.49
However, in the only 2 controlled studies that have
searched for CD in patients with RAS,47,48 histologic
signs of CD have been demonstrated in nearly 5% of
patients with RAS, whereas none of the biopsies obtained
from controls revealed the disease.
The evidence of a correlation between the 2
conditions was less robust when we considered studies,
which examined the prevalence of RAS in CD patients
(Table 5). In fact, 9.66%64 to 26.53%32 of celiac subjects
resulted with RAS in uncontrolled studies, a prevalence
similar to that estimated for the general population.
Furthermore, all the controlled studies14,16,21,60 failed to
demonstrate any statistically signiﬁcant diﬀerence be-
tween CD and control groups, even though it is worth
noting that prevalence values of RAS resulted constantly
higher in celiac patients than controls.
A support for the hypothetical correlation between
CD and RAS is provided by the observation that GFD
may be eﬀective in the management of RAS. In fact,
several authors reported signiﬁcant improvement, if not
complete remission, of oral aphthae in most CD patients
which had been placed on GFD,16,46,55,65 and reappear-
ance of recurrences with the reintroduction of glu-
ten.52,54,62,63 Furthermore, patients with RAS and no
histologic evidence of CD showed a favorable response to
GFD and a positive gluten challenge, suggesting
the existence of a form of gluten-sensitive RAS.66 On
the other hand, a double-blind controlled study examined
the eﬀect of GFD in patients with RAS and without CD;
4 of the 11 subjects on GFD reported beneﬁt as
regards the oral aphthae, but no signiﬁcant statistical
diﬀerence was observed as compared with control
subjects which underwent GFD supplemented by gluten
given blind.67
Concerning the severity of aphthae in CD subjects,
most papers assert that celiac patients with RAS suﬀer
from minor aphthae.53,55,57,62,63 However, cases of CD
patients with major or herpetiform RAS were also
reported.54
A possible explanation for the hypothetical correla-
tion between CD and RAS is that oral aphthae in CD
patients could be related to hematinic deﬁciencies (iron,
folic acid, or vitamin B12). In fact, about 20% of subjects
with RAS may have a hematinic deﬁciency,43 and the
serum levels of iron, folic acid, and vitamin B12 are
usually low in patients with untreated CD.68 Consistently
with this hypothesis, hemoglobin and serum folate levels
were found signiﬁcantly lower in patients aﬀected by both
RAS and CD than in nonceliac subjects with RAS.46,58
Moreover, all the 5 cases of CD diagnosed in a series of
TABLE 4. Prevalence of CD in Patients With RAS
Study Group (Patients With RAS)
Control Group
(Subjects Without RAS)
Author, Year
No.
Patients
Type of
RAS
Prevalence
of CD (%)
No.
Subjects
Prevalence
of CD (%)
CD Diagnostic
Criteria P
Olszewska et al,47 2006 42 NR 4.76 42 0 Biopsy >0.05
Aydemir et al,48 2004 41 NR 4.88 49 0 Biopsy NR
Robinson et al,49 2004 87 Minor 0 — — Biopsy —
Nowak et al,50 2002 20 NR 5 — — IgA EMA —
Jokinen et al,51 1998 27 NR 11.11 — — Biopsy —
Tavarela Veloso et al,52 1987 24 NR 16 — — Biopsy —
Merchant et al,53 1986 100 Minor 1 — — Biopsy —
Tyldesley,54 1981 97 min., maj., her. 6.18 — — Biopsy —
Ferguson et al,55 1980 50 Minor 4 — — Biopsy —
Rose et al,56 1978 26 NR 3.84 — — Biopsy —
Ferguson et al,46 1976 33 NR 24.24 — — Biopsy —
Wray et al,57 1975 130 Minor 3.84 — — Biopsy —
Ferguson et al,58 1975 35 NR 20 — — Biopsy —
EMA indicates endomysium antibodies; her., herpetiform; min., minor; maj., major; NR, not reported.
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130 patients with RAS were deﬁcient in iron, vitamin B12,
or folic acid.57
Immuno-genetical factors could be also involved in
this presumptive association, as the prevalence of HLA
antigens DRw10 and DQw1 was demonstrated signiﬁ-
cantly higher in patients with CD and RAS than in
patients with CD only.62,63 However, whether CD and
CD-associated aphthous ulcers are the consequence of a
similar immunopathologic mechanism remains a matter
of conjecture.
Atrophic Glossitis
A series of 128 patients with CD and 30 healthy
controls was examined for oral mucosal lesions and
symptoms in a Finnish study.21 The tongue was most
frequently aﬀected, as 29.68% of CD patients referred
soreness or burning sensation of the tongue (with a
statistically signiﬁcant diﬀerence as compared with
control subjects) and 8.59% showed erythema or atrophy.
We can report the case of a man with erythema and
atrophy on the dorsum of the tongue and without
gastrointestinal complaints, whose serologic tests for
CD were positive; the small-intestine biopsy conﬁrmed
the diagnosis of CD, and GFD resulted in resolution of
the tongue lesion.69
We found no more paper that supports a correlation
between CD and glossitis. However, iron and vitamin B12
deﬁciencies are frequent in untreated CD patients,68 and
it is well known that such deﬁciencies may cause atrophic
glossitis, often accompanied by soreness or burning
sensation.70 Furthermore, several reports describe cases
of CD associated with Plummer-Vinson syndrome.71–77
Plummer-Vinson syndrome (also referred as Paterson-
Brown Kelly syndrome, or sideropenic dysphagia) is a
rare condition that comprises the classic triad of
dysphagia, iron-deﬁciency anemia, and esophageal webs;
other clinical features may also be observed, among these
atrophic glossitis.78
Oral Lichen Planus
Oral lichen planus (OLP) is a chronic inﬂammatory
disorder aﬀecting the oral mucosa with a spectrum of
clinical conditions, including keratotic, atrophic, erosive,
and ulcerative lesions.79
In 1993, an unusual association of OLP and CD was
reported.80 This was the case of a 70-year-old male with a
biopsy-proven erosive OLP; iron, folate, and vitamin B12
deﬁciencies led to perform jejunal biopsy, that demon-
strated CD. Surprisingly, GFD resulted in relief of OLP
within 6 month. But the hypothesis of an association
between CD and OLP was promptly refuted by Scully
et al,81 who 1 month later referred that they had
investigated 103 patients with OLP and none had CD.
So, they replied that OLP would seem only occasionally
associated with CD.
In 1998, 39 consecutive patients with OLP were
screened for CD; 12 were positive for IgA gliadin
antibody test and 2 for endomysium antibody test, but
only 1 had small intestinal signs of CD.51 We found only
another anecdotal report that describes OLP in a CD
patient.82 Thus, there is currently insuﬃcient evidence to
support an association between CD and OLP.
Oral Manifestations of DH
DH is a pruritic bullous skin disease considered as a
part of the spectrum of gluten-sensitive disorders. In fact,
although patients with DH are unlikely to have gastro-
intestinal complaints, nearly all of them have some degree
of small intestinal histopathologic changes identical to
those of CD, and they share the same serologic antibody
proﬁle of celiac subjects.83 Moreover, GFD is an eﬀective
therapy for DH, which conﬁrms the role of an intestinal
reaction to gluten in the pathogenesis of DH.84 Typically,
DH consists of symmetrical, erythematous, papulo-
vesicular lesions that generally involve the extensor
surfaces of the elbows, knees, buttocks, and scalp. Owing
TABLE 5. Prevalence of RAS in Patients With CD
Study Group (Patients With CD) Control Group (Subjects Without CD)
Author, Year
No.
Patients
Prevalence of
RAS (%) Type of RAS
No.
Subjects
Prevalence
of RAS (%)
Type of
RAS
CD Diagnostic
Criteria P Value
Bucci et al,16 2006 72 33.33 NR 162 23.45 NR Biopsy >0.05
Sood et al,59 2003 96 19.79 NR — — — ESPGAN, 1990 —
Sedghizadeh et al,60 2002 61 40.98 NR 62 27.41 NR NR 0.1127
La¨hteenoja et al,21 1998 128 3.12 NR 30 0 — Biopsy 0.327
Petrecca et al,29 1994 29 17.24 NR — — — Biopsy —
Corazza et al,61 1993 226 15.93 NR — — — Biopsy —
Meini et al,62 1993;
Majorana et al,63 1992
113 17.69 Minor — — — ESPGAN, 1990 —
Balli et al,32 1988 49 26.53 NR — — — SIP —
Biemond et al,64 1987 414 9.66 NR — — — biopsy —
Andersson-Wenckert et al,14
1984
19 31.58 NR 19 26.31 NR Biopsy NR
ESPGAN indicates European Society of Paediatric Gastroenterology and Nutrition (reference of the diagnostic criteria: Walker-Smith et al,35 1990); NR, not reported;
SIP, Societa` Italiana di Pediatria (Italian Society of Pediatrics; reference of the diagnostic criteria: Italian Society of Pediatrics,36 1978).
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to their intense itching, lesions often look as skin erosions
secondary to scratching.
In a study on 15 patients with DH, oral lesions were
found in 12 cases.85 Oral involvement consisted of
erythematous, pseudo-vesicular, purpuric, and erosive
lesions, but only in 2 cases the direct immunoﬂuorescence
examination revealed the typical granular deposits of IgA
along the basement membrane, that is a sine qua non for
the diagnosis of DH. Similarly, 57% of 27 patients with
DH were found as having oral lesions, which included
ulcerations, erythemas, and atrophies86; however, no
direct immunoﬂuorescence study was performed.
To the contrary, no oral mucosal involvement was
described in a large review of 926 cases of DH,87 and only
1 case of small oral blisters was reported in a study on 149
DH patients.88 Rather, in an old paper89 the absence of
oral lesions was referred as a diagnostic criterion for DH.
Actually, at present oral involvement in DH is
considered very rare, and generally consists of vesicles
and bullae that result in ulcers.90 Reports that describe
DH lesions in the oral cavity are sparse91–95; 2 of
these91,95 relate cases of oral manifestations appeared
before the onset of the skin lesions.
Other Oral Soft Tissue Lesions
Oral mucosal malignancies were described in celiac
patients; these include carcinoma of the tongue72,96,97 and
oral T-cell lymphoma.98 Occurrence of T-cell lymphoma
in the oral cavity is uncommon for celiac patients, as CD-
related lymphomas usually develop in the upper small
intestine. In addition, 8 cancers of oral cavity and
pharynx were detected out of 11,019 CD subjects.99
A case of oral mucosal melanosis was observed in a
32-year-old celiac woman, also aﬀected by neuropathies
and unspeciﬁed ‘‘dental irregularities’’100; GFD resulted
in improvement of neurologic ﬁndings, but not of oral
hyperpigmentation.
An occasional association of CD and cicatricial
pemphigoid with involvement of tongue, buccal mucosa,
gingiva, and ﬂoor of mouth has been recently reported in
a 14-year-old girl.101
DISCUSSION
Contrary to early beliefs, CD is a relatively common
disease, with a mortality rate higher than that of the
general population, mainly owing to long-term complica-
tions (eg, autoimmune diseases, malignancies). Diagnosis
of CD is relatively easy in cases with typical signs and
symptoms (ie, chronic diarrhea, abdominal pain and
distention, weight loss). However, the majority of patients
suﬀers from atypical or silent forms, for which diagnosis
is often diﬃcult. As a consequence, although its estimated
prevalence is nowadays signiﬁcantly higher than pre-
viously thought, it is reasonable to presume that CD still
remains underdiagnosed.102
CD fulﬁls the WHO criteria for mass screenings.103
In fact, it is a common disorder with a signiﬁcant
morbidity and an eﬀective treatment; its early detection
could be diﬃcult on a clinical basis; if not diagnosed, it
could result in severe complications diﬃcult to manage.
Moreover, although the small intestinal biopsy remains
the gold standard for the diagnosis of CD, current
diagnostic serologic tests (mostly endomysium antibodies
and tissue transglutaminase antibodies) have optimal
speciﬁcity and sensitivity approaching 100%.104 Thus,
they are suitable as screening tests. However, at present
there is insuﬃcient evidence to recommend mass screen-
ing for CD, while case-ﬁnding in high-risk groups
(ie, subjects with clinical conditions well-known to be
associated with CD) seems eﬀective, and currently
represents the best epidemiologic approach to detect
atypical cases.105 First-degree relatives of celiac indivi-
duals and subjects with type I diabetes, autoimmune
thyroid disease, unexplained osteoporosis, unexplained
abnormal liver biochemistry, irritable bowel syndrome,
and unexplained infertility or miscarriage are considered
at-risk groups105; for them serologic CD testing should be
considered.
A few oral ailments have been described in celiac
patients. Among these, systematic DEDs are those with
the strongest evidence of a correlation with CD, and
should be counted in the extraintestinal manifestations of
the disease. Subjects with systematic DEDs should be
considered at-risk for CD, and thus they should undergo
serologic screening tests for gluten intolerance.
As regards aphthous ulcers, although an association
with CD should seem plausible. Currently, we lack robust
evidence-based data to recommend CD screening tests for
subjects with recurrent aphthae. However, hematologic
investigations (such as full blood cell count and measure-
ment of serum iron, ferritin, vitamin B12, and folic acid)
are often included in the standard diagnostic protocols
for RAS,43 albeit elements in support of routine
hematologic testing in patients with aphthae are lack-
ing.45 At any rate, a suspicion of CD should arise in cases
of RAS associated with hematinic deﬁciencies. Similarly,
CD testing could be considered in those patients with
idiopathic atrophic glossitis for which hematologic
investigations reveal an underlying haematinic deﬁciency.
In summary, oral cavity may be involved in CD.
DEDs are the oral lesions most closely related to CD;
patients with systematic enamel defects have to be
recognized as at-risk subjects, and they should undergo
screening tests even in the absence of gastrointestinal
symptoms. On the other hand, there is insuﬃcient
evidence to recommend routine CD screening tests for
patients with RAS, and also for subjects with idiopathic
atrophic glossitis. Nevertheless, we would alert physicians
and dental practitioners to consider CD in managing
these patients, especially if clinical conditions that could
be the result of CD are present.
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